5-<wbr/>Fluorocytosine

5-Fluorocytosine

CAT N°: 11635
Price:

From 74.00 62.90

5-Fluorocytosine (5-FC), a fluorinated pyrimidine analog, is a synthetic antimycotic prodrug that is converted by cytosine deaminase to 5-fluorouracil.{20805} 5-Fluorouracil, a widely used cytotoxic drug, is further metabolized to fluorinated ribo- and deoxyribonucleotides, resulting in the inhibition of DNA and protein synthesis, which has multiple effects including inhibition of Candida species and C. neoformans infections and cytotoxicity towards cancer cells.{20805,20804} In combination with a retroviral replicating vector carrying a cytosine deaminase prodrug-activating gene, 5-FC has been shown to selectively eliminate CT26 and Tu-2449 tumor cells in vitro (IC50s = 4.2 and 1.5 ?M, respectively) and to significantly improve survival and reduce tumor size (at a dose of 500 mg/kg) in two different syngeneic mouse glioma models.{20803}

Territorial Availability: Available through Bertin Technologies only in France

  • Synonyms
    • 6-amino-5-fluoro-2(1H)-pyrimidinone
  • Correlated keywords
    • flucytosin fluocytosine fluorocytosine alcobon ancotyl prodrugs 5-fluorouracil cytotoxic inhibitors inhibits inhibition Candida species Cryptococcus neoformans viral infection cancers cytosine deaminase 5 fluorocytosine fluorine drugs DNA proteins sybthesis cells CT26 Tu-2449 tumors flucytosine
  • Product Overview:
    5-Fluorocytosine (5-FC), a fluorinated pyrimidine analog, is a synthetic antimycotic prodrug that is converted by cytosine deaminase to 5-fluorouracil.{20805} 5-Fluorouracil, a widely used cytotoxic drug, is further metabolized to fluorinated ribo- and deoxyribonucleotides, resulting in the inhibition of DNA and protein synthesis, which has multiple effects including inhibition of Candida species and C. neoformans infections and cytotoxicity towards cancer cells.{20805,20804} In combination with a retroviral replicating vector carrying a cytosine deaminase prodrug-activating gene, 5-FC has been shown to selectively eliminate CT26 and Tu-2449 tumor cells in vitro (IC50s = 4.2 and 1.5 ?M, respectively) and to significantly improve survival and reduce tumor size (at a dose of 500 mg/kg) in two different syngeneic mouse glioma models.{20803}

We also advise you